89 related articles for article (PubMed ID: 34823564)
1. Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer.
Jiang L; Zhang L; Shu Y; Zhang Y; Gao L; Qiu S; Zhang W; Dai W; Chen S; Huang Y; Liu Y
J Biol Chem; 2024 Apr; 300(4):107171. PubMed ID: 38492776
[TBL] [Abstract][Full Text] [Related]
2. The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.
Chen L; Wang Z; Xu Q; Liu Y; Chen L; Guo S; Wang H; Zeng K; Liu J; Zeng S; Yu L
Theranostics; 2020; 10(8):3562-3578. PubMed ID: 32206108
[No Abstract] [Full Text] [Related]
3. DNA methylation regulates B cell activation via repressing Pax5 expression in teleost.
Shi Y; Zhu Z; Chen Q; Chen X
Front Immunol; 2024; 15():1363426. PubMed ID: 38404580
[TBL] [Abstract][Full Text] [Related]
4.
Zhang Y; Feng J; Mi Y; Fan W; Qin R; Mei Y; Jin G; Mao J; Zhang H
Drug Metab Dispos; 2024 Apr; ():. PubMed ID: 38565301
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon.
Hong YD; Zhang J; Zhuang M; Li W; Wu PU; Li RT; Hu N; Bian BX; Song ZY; Wu FL
Oncotarget; 2017 Dec; 8(70):114495-114505. PubMed ID: 29383097
[TBL] [Abstract][Full Text] [Related]
6. Fasting-induced RNF152 resensitizes gallbladder cancer cells to gemcitabine by inhibiting mTORC1-mediated glycolysis.
Tao Y; Gong Z; Shen S; Ding Y; Zan R; Zheng B; Sun W; Ma C; Shu M; Lu X; Liu H; Ni X; Liu H; Suo T
iScience; 2024 May; 27(5):109659. PubMed ID: 38706841
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic changes in carcinogenesis of gallbladder.
Tewari M; Agarwal A; Mishra RR; Meena RN; Shukla HS
Indian J Surg Oncol; 2013 Dec; 4(4):356-61. PubMed ID: 24426757
[TBL] [Abstract][Full Text] [Related]
8. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
[TBL] [Abstract][Full Text] [Related]
9. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944.
Gao G; Li X; Wu H; Huang LL; Lin YX; Huo Z; Xiang ZY; Zhou X
Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259332
[TBL] [Abstract][Full Text] [Related]
11. MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7.
Hu X; Zhang J; Bu J; Yang K; Xu S; Pan M; Xiang D; Chen W
Bioengineered; 2022 Apr; 13(4):10691-10706. PubMed ID: 35443866
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.
Xu S; Zhan M; Jiang C; He M; Yang L; Shen H; Huang S; Huang X; Lin R; Shi Y; Liu Q; Chen W; Mohan M; Wang J
Nat Commun; 2019 Dec; 10(1):5492. PubMed ID: 31792210
[TBL] [Abstract][Full Text] [Related]
13. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
Shi Y; Fan Y; Hu Y; Jing J; Wang C; Wu Y; Geng Q; Dong X; Li E; Dong D
J Cell Mol Med; 2020 Jan; 24(1):760-771. PubMed ID: 31762191
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
Zhang GF; Wu JC; Wang HY; Jiang WD; Qiu L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32869841
[TBL] [Abstract][Full Text] [Related]
15. The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.
Dingle BH; Rumble RB; Brouwers MC;
Can J Gastroenterol; 2005 Dec; 19(12):711-6. PubMed ID: 16341310
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
Xu S; Jiang C; Lin R; Wang X; Hu X; Chen W; Chen X; Chen T
J Exp Clin Cancer Res; 2021 Nov; 40(1):373. PubMed ID: 34823564
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
